Leukemia and lymphomas, malignant neoplasms of the white blood cells, are the most common childhood cancers. Since the early 1970s, almost all children and adolescents who develop leukemia or lymphoma in Germany have been treated in clinical trials. As a result, these cancers, which used to be regularly fatal, can now be cured in most patients. Today, we are working to further improve the prospects of cure for young patients with blood cancer.
We treat almost all patients with leukemia and lymphomas in the context of patient registries or clinical trials. In doing so, we pursue the following goals:
- Standardized diagnostics and therapy are intended to ensure that each patient receives the treatment appropriate for his or her disease.
- Data on the course and treatment of leukemia and lymphomas are intended to further improve therapy, for example by monitoring at which point in therapy complications occur particularly frequently
